December 2024 ASX Penny Stocks To Watch

The Australian market is poised for a positive start this Tuesday, with the ASX 200 expected to rise by 0.75% as Black Friday sales kick off the anticipated Santa rally. For investors looking beyond established giants, penny stocks—typically smaller or newer companies—offer intriguing possibilities despite being considered a niche area. These stocks can still provide growth opportunities when supported by strong financial health, allowing investors to uncover hidden value in quality companies.

Top 10 Penny Stocks In Australia

Name	Share Price	Market Cap	Financial Health Rating
Embark Early Education (ASX:EVO)	A$0.79	A$144.95M	★★★★☆☆
LaserBond (ASX:LBL)	A$0.565	A$66.23M	★★★★★★
Helloworld Travel (ASX:HLO)	A$2.03	A$330.52M	★★★★★★
Austin Engineering (ASX:ANG)	A$0.54	A$334.88M	★★★★★☆
MaxiPARTS (ASX:MXI)	A$1.76	A$97.36M	★★★★★★
EZZ Life Science Holdings (ASX:EZZ)	A$2.41	A$111.24M	★★★★★★
SHAPE Australia (ASX:SHA)	A$2.75	A$228.01M	★★★★★★
Navigator Global Investments (ASX:NGI)	A$1.65	A$808.63M	★★★★★☆
Vita Life Sciences (ASX:VLS)	A$2.03	A$114.16M	★★★★★★
Servcorp (ASX:SRV)	A$4.87	A$480.5M	★★★★☆☆

Click here to see the full list of 1,044 stocks from our ASX Penny Stocks screener.

Let's review some notable picks from our screened stocks.

Atlas Pearls (ASX:ATP)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Atlas Pearls Limited is an Australian company engaged in the production and sale of South Sea pearls, primarily operating in Australia and Indonesia, with a market capitalization of A$74.07 million.

Operations: The company generates revenue from the sale of loose pearls, with A$39.77 million attributed to its operations in Australia and A$25.03 million from Indonesia.

Market Cap: A$74.07M

Atlas Pearls, with a market cap of A$74.07 million, has shown significant financial improvement, becoming profitable over the past five years and achieving an impressive earnings growth of 246.3% in the last year alone. The company operates debt-free, which eliminates concerns about interest coverage and enhances financial stability. Its net profit margins have improved substantially to 75.5%, supported by a seasoned management team averaging 12 years of tenure. Although shareholders experienced dilution with shares outstanding increasing by 2.6%, Atlas Pearls trades significantly below its estimated fair value while maintaining strong short-term asset coverage for liabilities.

• Get an in-depth perspective on Atlas Pearls' performance by reading our balance sheet health report here.
• Learn about Atlas Pearls' historical performance here.

GreenX Metals (ASX:GRX)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: GreenX Metals Limited is involved in the exploration and evaluation of mineral properties across Greenland, Poland, and Germany, with a market cap of A$188.66 million.

Operations: The company's revenue segment consists solely of Mineral Exploration, generating A$0.46 million.

Market Cap: A$188.66M

GreenX Metals Limited, with a market cap of A$188.66 million, is pre-revenue and focuses on mineral exploration across Greenland, Poland, and Germany. The company remains debt-free and has strong short-term asset coverage over liabilities. Recent developments at its Eleonore North project in Greenland reveal high-grade antimony mineralisation amidst rising global demand due to China's export controls. This strategic shift aligns well with the company's seasoned management team as they explore the antimony-gold potential further. However, shareholders have experienced dilution recently, reflecting typical volatility associated with penny stocks in this sector.

• Take a closer look at GreenX Metals' potential here in our financial health report.
• Assess GreenX Metals' previous results with our detailed historical performance reports.

OFX Group (ASX:OFX)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: OFX Group Limited offers international payments and foreign exchange services across the Asia Pacific, North America, Europe, the Middle East, and Africa with a market cap of A$330.66 million.

Operations: The company's revenue is derived from the Asia Pacific with A$91.22 million, North America contributing A$88.75 million, and Europe generating A$36.80 million.

Market Cap: A$330.66M

OFX Group, with a market cap of A$330.66 million, operates in international payments and foreign exchange services across multiple regions. Despite recent negative earnings growth and reduced profit margins, the company maintains high-quality past earnings and a well-covered debt by operating cash flow. The board is experienced; however, management is relatively new with an average tenure of two years. OFX's share price has been volatile but remains undervalued compared to peers. Recent buybacks have reduced outstanding shares by 4.19%, indicating confidence in future performance despite lower net income reported for the half year ended September 2024 compared to the previous year.

• Navigate through the intricacies of OFX Group with our comprehensive balance sheet health report here.
• Understand OFX Group's earnings outlook by examining our growth report.

Make It Happen

• Dive into all 1,044 of the ASX Penny Stocks we have identified here.
• Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com